Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2018, Article ID 3271948, 20 pages
https://doi.org/10.1155/2018/3271948
Review Article

Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers

Department of Physiology and Pharmacology, School of Medicine, University of Cantabria and Instituto de Investigación Valdecilla (IDIVAL), 39011 Santander, Spain

Correspondence should be addressed to Carlos Martínez-Campa; se.nacinu@mczenitram

Received 11 June 2018; Revised 30 July 2018; Accepted 12 August 2018; Published 2 October 2018

Academic Editor: Dario Acuña-Castroviejo

Copyright © 2018 Javier Menéndez-Menéndez and Carlos Martínez-Campa. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • Karin Golan, Orit Kollet, Regina P. Markus, and Tsvee Lapidot, “Daily light and darkness onset and circadian rhythms metabolically synchronize hematopoietic stem cell differentiation and maintenance: The role of bone marrow norepinephrine, TNF and melatonin cycles,” Experimental Hematology, 2019. View at Publisher · View at Google Scholar
  • Sankha Bhattacharya, Krishna Kumar Patel, Deepa Dehari, Ashish Kumar Agrawal, and Sanjay Singh, “Melatonin and its ubiquitous anticancer effects,” Molecular and Cellular Biochemistry, 2019. View at Publisher · View at Google Scholar
  • Edilson Ribeiro de Oliveira Junior, Thais Leite Nascimento, Mariana Arraes Salomão, Artur Christian Garcia da Silva, Marize Campos Valadares, and Eliana Martins Lima, “Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma,” Pharmaceutical Research, vol. 36, no. 9, 2019. View at Publisher · View at Google Scholar
  • Balasunder R. Dodda, Corry D. Bondi, Mahmud Hasan, William P. Clafshenkel, Katie M. Gallagher, Mary P. Kotlarczyk, Shalini Sethi, Ethan Buszko, Jean J. Latimer, J. Mark Cline, Paula A. Witt-Enderby, and Vicki L. Davis, “Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer,” Frontiers in Oncology, vol. 9, 2019. View at Publisher · View at Google Scholar
  • Javier Menéndez-Menéndez, Francisco Hermida-Prado, Rocío Granda-Díaz, Alicia González, Juana María García-Pedrero, Nagore Del-Río-Ibisate, Alicia González-González, Samuel Cos, Carolina Alonso-González, and Carlos Martínez-Campa, “Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin,” Cancers, vol. 11, no. 7, pp. 1011, 2019. View at Publisher · View at Google Scholar
  • Hunsaker, Barba, Kingsley, and Howard, “Differential MicroRNA Expression of miR-21 and miR-155 within Oral Cancer Extracellular Vesicles in Response to Melatonin,” Dentistry Journal, vol. 7, no. 2, pp. 48, 2019. View at Publisher · View at Google Scholar
  • Dake Zhao, Yang Yu, Yong Shen, Qin Liu, Zhiwei Zhao, Ramaswamy Sharma, and Russel J. Reiter, “Melatonin Synthesis and Function: Evolutionary History in Animals and Plants,” Frontiers in Endocrinology, vol. 10, 2019. View at Publisher · View at Google Scholar
  • Hadis Zare, Rana Shafabakhsh, Russel J. Reiter, and Zatollah Asemi, “Melatonin is a potential inhibitor of ovarian cancer: molecular aspects,” Journal of Ovarian Research, vol. 12, no. 1, 2019. View at Publisher · View at Google Scholar
  • Mohammad Mirza-Aghazadeh-Attari, Amir Mohammadzadeh, Ali Adib, Saber Ghazizadeh Darband, Shirin Sadighparvar, Ainaz Mihanfar, Maryam Majidinia, and Bahman Yousefi, “Melatonin-mediated regulation of autophagy: Making sense of double-edged sword in cancer,” Journal of Cellular Physiology, 2019. View at Publisher · View at Google Scholar
  • Rana Shafabakhsh, Hamed Mirzaei, and Zatollah Asemi, “Melatonin: A promising agent targeting leukemia,” Journal of Cellular Biochemistry, 2019. View at Publisher · View at Google Scholar
  • Franciele Aline Bruinsmann, Gustavo Richter Vaz, Aline de Cristo Soares Alves, Tanira Aguirre, Adriana Raffin Pohlmann, Silvia Stanisçuaski Guterres, and Fabio Sonvico, “Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials,” Molecules, vol. 24, no. 23, pp. 4312, 2019. View at Publisher · View at Google Scholar
  • Bianka Bojková, Karol Kajo, Peter Kubatka, Peter Solár, Martin Péč, and Marián Adamkov, “Metformin and melatonin improve histopathological outcome of NMU-induced mammary tumors in rats,” Pathology - Research and Practice, 2019. View at Publisher · View at Google Scholar